VRX Related Trader Talk
-
Valeant (VRX), Mylan (MYL) on Watch as Actavis (ACT) Buys Warner Chilcott (WCRX)
-
Warner Chilcott (WCRX) Volatile as Actavis (ACT) Has a New Bidder
-
Actavis (ACT) Said to be in Talks to Acquire Warner Chilcott (WCRX)
-
Valeant (VRX) Volatile as Actavis (ACT) Seeks Its Own Deal
-
Valeant Pharmaceuticals (VRX) Near Deal to Acquire Actavis (ACT) for Over $13B
-
Options Whittling Down for Endo Health (ENDP) as CEO Holveck Departs
-
Endo Pharma (ENDP) Possibly in Talks to Sell Itself - Reuters
-
Pre-Open Movers 5/2: (ICO) (CEPH) (TIVO) Higher; (YRCW) (VRX) (SLW) Lower (more...)
-
Valeant Pharmaceuticals (VRX) Slammed After Losing Cephalon (CEPH) Bidding
-
Cephalon (CEPH) Trades Down Slightly After Rejecting Valeant's (VRX) Offer
-
Valeant Pharmaceuticals (VRX) On Watch Related to Cephalon (CEPH) Halt
-
Takeover Target Cephalon (CEPH) Moves to Highs
-
Wall Street Mixed On Additional Upside in Cephalon (CEPH) Following Takeover Bid
-
Pre-Open Movers 3/30: (CEPH) (VRX) (BLK) Higher; (UTA) (VVTV) (ZZ) Lower
-
Cephalon (CEPH) Shares Resume Trading $4 Over Valeant's (VRX) $73/Share Bid
-
Valeant Pharmaceuticals (VRX) Trades Higher Despite Bid
-
Cephalon (CEPH) will resume trading at 7:10AM after takeover bid
-
Biotech Stocks Could See Action On Valeant (VRX) Bid for Cephalon (CEPH): (BIIB) (JAZZ) (DNDN) (REGN) (more...)
-
Alexza (ALXA) Receives CRL From FDA On AZ-004 Stating It is Not Ready for Approval, Shares Plunge
-
S&P Announces Changes to Indices: BEZ for VRX in MidCap 400, UHT for BEZ in SmallCap 600
-
Valeant (VRX), Biovail (BVF) Shares Move to New 52-Week Highs as Pearson Gives Details of Integration; National Bank Upgrades BVF to Outperform
-
JANA Partners 13F Shows New Stakes in Genentech (DNA), Sears (SHLD), Washington Mutual (WM); Adds to Positions in AK Steel (AKS), Focus Media (FMCN), Transocean (RIG); Sells Out of Apple (AAPL), Lehma
-
NasdaqTrader Notes Trading in SYMM, VRX, CSS is Halted
Back to VRX Stock Lookup
